st-246 and Leukemia--Myeloid--Acute

st-246 has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for st-246 and Leukemia--Myeloid--Acute

ArticleYear
Preemptive Tecovirimat Use in an Active Duty Service Member Who Presented With Acute Myeloid Leukemia After Smallpox Vaccination.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-27, Volume: 69, Issue:12

    Smallpox vaccine is contraindicated in immunosuppression due to increased risk for adverse reactions (eg, progressive vaccinia). We describe the first-ever use of tecovirimat as a preemptive vaccinia virus treatment strategy during induction chemotherapy in an active duty service member who presented with acute leukemia and inadvertent autoinoculation after smallpox vaccination.

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Benzamides; Humans; Immunoglobulins, Intravenous; Isoindoles; Leukemia, Myeloid, Acute; Male; Military Personnel; Premedication; Smallpox; Smallpox Vaccine; Symptom Assessment; Treatment Outcome; Vaccination; Vaccinia virus

2019